Amrize: pricing and deals lift Q3 growth, Building Envelope recovery pushed to 2027
Amrize's Q3 growth was supported by pricing and acquisitions, it updated FY2026 guidance, and expects Building Envelope recovery in 2027.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Amrize's third-quarter growth was supported by higher prices and acquisitions, even though weather weighed on volumes and cost inflation continued. The company updated its fiscal 2026 guidance for revenue and EBITDA.
The company expects Building Materials to reach a positive price-over-cost balance in the fourth quarter, while recovery in the Building Envelope segment has been pushed back to 2027. The information comes from TradingView, which notes that the text is an AI-generated summary and may contain inaccuracies.
why it matters
Delaying the Building Envelope recovery to 2027 suggests cost pressure could last longer than expected. Investors in AMRZ will watch the updated guidance and margin trends in Building Materials in the final quarter of the year.
market impact
AMRZ: lasting cost pressure and updated guidance weigh on sentiment toward the company's shares
tags
instruments
sources
- AMRZ: Pricing and acquisitions supported Q3 growth, while cost inflation delayed Building Envelope recovery to 2027 — TradingView, 29 October 2026 at 16:06 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗